Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adebrelimab Plus Chemotherapy After SCRT in Locally Advanced Rectal Cancer
NCT07905950Phase 2Not yet recruiting
- Sponsor
- Henan Cancer Hospital
- Start
- Nov 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
A Phase 2 trial of adebrelimab in rectal cancer, sponsored by Henan Cancer Hospital. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
adebrelimab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT07905950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07905950.